Arbutus Biopharma Corp (NASDAQ:ABUS)

2.37
Delayed Data
As of 12:30pm ET
 +0.01 / +0.42%
Today’s Change
2.18
Today|||52-Week Range
12.60
-38.12%
Year-to-Date
No recent news for Arbutus Biopharma Corp.

Today’s Trading

Previous close2.36
Today’s open2.37
Day’s range2.33 - 2.47
Volume41,852
Average volume (3 months)251,461
Market cap$137.0M
Data as of 12:30pm ET, 05/21/2019

Growth & Valuation

Earnings growth (last year)+22.17%
Earnings growth (this year)-13.72%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-44.44%
P/E ratioNM
Price/Sales35.63
Price/Book1.81

Competitors

 Today’s
change
Today’s
% change
AQSTAquestive Therapeuti...-0.49-9.11%
OSMTOsmotica Pharmaceuti...-0.05-2.09%
ERYPErytech Pharma SA0.000.00%
SESNSesen Bio Inc+0.38+21.71%
Data as of 12:45pm ET, 05/21/2019

Financials

Next reporting dateAugust 15, 2019
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$5.9M
Annual profit (last year)-$57.1M
Net profit margin-959.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Mark J. Murray
Chief Financial &
Accounting Officer
David C. Hastings
Corporate headquarters
Burnaby, British Columbia

Forecasts